Jazz Pharmaceuticals
JAZZ
#1899
Rank
A$15.52 B
Marketcap
A$255.48
Share price
1.67%
Change (1 day)
33.38%
Change (1 year)

Market capitalization of Jazz Pharmaceuticals (JAZZ)

Market cap: A$15.52 Billion

As of December 2025 Jazz Pharmaceuticals has a market cap of A$15.52 Billion. This makes Jazz Pharmaceuticals the world's 1899th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Jazz Pharmaceuticals from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025A$15.52 B28.19%
2024A$12.11 B6.55%
2023A$11.36 B-22.89%
2022A$14.74 B36.46%
2021A$10.80 B-10.41%
2020A$12.05 B0.73%
2019A$11.96 B18.3%
2018A$10.11 B-2.14%
2017A$10.33 B14.14%
2016A$9.05 B-23.41%
2015A$11.82 B-2.5%
2014A$12.13 B47.8%
2013A$8.20 B176.13%
2012A$2.97 B87.17%
2011A$1.58 B105.16%
2010A$0.77 B182.37%
2009A$0.27 B308.24%
2008A$67.16 M-83.73%
2007A$0.41 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Jazz Pharmaceuticals was reported to be:

A$15.52 Billion
by Nasdaq info icon info icon
A$15.52 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Endo International
ENDPQ
A$0.21 M-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
A$54.42 B 250.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$381.77 B 2,359.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
A$49.15 B 216.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel